Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Mirtazapine

A tetracyclic antidepressant born in the Netherlands, described in 1989 by the same team of chemists who made mianserin, from which it differs by one extra nitrogen atom: approved in the Netherlands in 1994 and in the United States in 1996, it is used for major depression. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?In veterinary medicine it is used to stimulate appetite in cats: in 2018 the United States also approved it as an ointment applied to the inner surface of the ear.

MirtazapineGo to the active ingredient →
MirtazapineActive ingredientMirtazapineCat. No. P-M142-001CAS 85650-52-8
Mirtazapine-d4Isotopically labelledMirtazapine-d4Cat. No. P-M142-018CAS 1215898-55-7

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.